About FDA
Percentage of manufacturing supplements requiring prior approval with action due dates occurring during the month that were reviewed and acted upon within 4 months of receipt (1)
Dictionary: Licensed manufacturers must submit a prior approval supplement to FDA for any change to a product that has a substantial impact to have an adverse effect on the identity, strength, quality, purity or potency of the product as they may relate to the safety or effectiveness of the product. Examples of such changes include production process, quality controls, equipment, facilities, or responsible personnel. FDA approval must be obtained prior to distribution of the product made with the change. This measure will allow OCBQ to monitor its performance in issuing decisions for manufacturing supplements requiring prior approval within established timeframes.
Information is current as of September 30, 2012
Fiscal Year - 2012
| Time | Target | Value |
|---|---|---|
| Oct 2011 | 90 | 100 |
| Nov 2011 | 90 | 100 |
| Dec 2011 | 90 | 100 |
| Jan 2012 | 90 | N/A |
| Feb 2012 | 90 | 100 |
| Mar 2012 | 90 | 100 |
| Apr 2012 | 90 | 100 |
| May 2012 | 90 | 100 |
| Jun 2012 | 90 | 100 |
| Jul 2012 | 90 | 100 |
| Aug 2012 | 90 | 100 |
| Sep 2012 | 90 | 100 |
FY 2012 Overall: 90%
Footnotes
- (1) The monthly percentages are based on a denominator that excludes supplements that were withdrawn by the manufacturers prior to the due date.
Total number of manufacturing supplements requiring prior approval with action due dates occurring during the month that were reviewed and acted upon within 4 months of receipt
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 2 |
| Nov 2011 | N/A | 1 |
| Dec 2011 | N/A | 4 |
| Jan 2012 | N/A | 0 |
| Feb 2012 | N/A | 1 |
| Mar 2012 | N/A | 2 |
| Apr 2012 | N/A | 12 |
| May 2012 | N/A | 0 |
| Jun 2012 | N/A | 5 |
| Jul 2012 | N/A | 3 |
| Aug 2012 | N/A | 13 |
| Sep 2012 | N/A | 4 |
FY 2012 Total: 47
Total number of manufacturing supplements requiring prior approval with action due dates occurring during the month
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 2 |
| Nov 2011 | N/A | 1 |
| Dec 2011 | N/A | 6 |
| Jan 2012 | N/A | 0 |
| Feb 2012 | N/A | 1 |
| Mar 2012 | N/A | 3 |
| Apr 2012 | N/A | 12 |
| May 2012 | N/A | 1 |
| Jun 2012 | N/A | 5 |
| Jul 2012 | N/A | 3 |
| Aug 2012 | N/A | 13 |
| Sep 2012 | N/A | 5 |
FY 2012 Total: 52
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







